Trial intelligence / Profile preview

Oral vs IV Hydration with Foscavir in AIDS Patients with CMV Retinitis

NCT00002125Phase 4Completed

Sponsor
Astra Merck
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of foscarnet sodium in cytomegalovirus retinitis, sponsored by Astra Merck. Status: completed.

02

Drugs

foscarnet sodium
03

Conditions

cytomegalovirus retinitis

Beyond the preview

Go deeper on NCT00002125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call